CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Covaris›
Library
Covaris

Covaris

Covaris supplies acoustic sample-preparation instruments and kits for genomics and proteomics laboratories.

Operating headquarters
Woburn, MA, US🇺🇸
Founded
1999
Loading
Overview
Compare
Employees
Library

Covaris - Library

covaris.com·Crawled Oct 2, 2026·

Topics

Publication type

Content origin
Row density

Product

6 pages
  1. A Simplified High Throughput Cell-Based Assay for Increased Proteomic Coverage of Cardiomyocytes/simplified-htp-cell-based-for-proteomics

    At ASMS 2023, Saeed Seyedmohammad, Ph.D., Staff Scientist at Cedars-Sinai Medical Institute, presented the results of an ultrasonication-assisted tryptic digestion method to increase protein coverage using Covaris’ Adaptive Focused Acoustics® (AFA®) technology. Read on to learn how incorporating AFA technology into a simplified detergent-free protein extraction workflow enabled deeper proteome coverage of biologically perturbed cardiomyocytes, […]

  2. AFA Assisted Workflow for High Throughput Mass Spectrometry-Based Proteomic Analysis of FFPE Samples/afa-assisted-workflows-2
  3. AFA Assisted Workflows for High Throughput Mass Spectrometry-Based Proteomic Analysis of FFPE Samples/afa-assisted-workflows
  4. High-Throughput Genomic Profiling of Solid Tumor FFPE Specimens with Fully Automated Extraction—How a New Platform is Changing Clinical Testing and Cancer Research/high-throughput-genomic

    Labcorp, Covaris, and Hamilton came together at AMP2024 to showcase a fully automated, high-throughput solution for extracting DNA and RNA from formalin-fixed paraffin-embedded (FFPE) solid tumor samples. The Hamilton Sonication STAR, enabled by Covaris truXTRAC® FFPE SMART Solutions, improves sequencing outcomes by minimizing quantity not sufficient (QNS) failures and increasing the proportion of fully reported […]

Blog

5 pages
  1. A Rapid Workflow for High-Throughput FFPE-Based Proteomics/high-throughput-ffpe-based-proteomics-rapid-workflow

    [vc_row][vc_column][vc_column_text css=””]At ASMS 2023, Benjamin Madden, PhD, Staff Scientist at the Mayo Clinic Proteomics Core, presented results of a simplified laser capture microdissection (LCM) FFPE tissue processing workflow developed for proteomics research. The work, conducted within the Mayo Clinic Proteomics Core, directed by Dr. Akhilesh Pandey, incorporated Adaptive Focused Acoustics® (AFA®) technology-assisted digestion using Covaris’ R230 Focused-ultrasonicator. The use of a plate

  2. Biology at the Speed of Sound/maximizing-proteinextraction-gadzukshea-wang

    Biology at the speed of sound brought to you by Covaris AFA-technology, saving time, money and samples for genetics, proteomics, cell biology, drug discovery and more

  3. Get More Out of Your Flow Cell with 3X Fold Enrichment/3x-fold-enrichment

    DNA fragmentation, a key step in next-generation sequencing (NGS) library preparation, is primarily achieved through two methods: mechanical and enzymatic shearing. Mechanical fragmentation uses physical forces (e.g., ultrasonication or nebulization) to break DNA into smaller fragments. In contrast, enzymatic shearing utilizes specific enzymes to cut DNA strands at specific points.1 Figure 1. 3x Fold Enrichment11 […]

  4. Leveraging AFA Ultrasonication as a Versatile Sample Preparation Tool for Proteomics Core Facilities/leveraging-afa-ultrasonication

    [vc_row][vc_column][vc_column_text css=””]During ASMS 2023, Jennifer Roof, a Research Technician with the CHOP-Penn Proteomics Core Facility at the Children’s Hospital of Philadelphia, University of Pennsylvania, shared how Covaris’ R230 Focused-ultrasonicator, powered by Adaptive Focused Acoustics® (AFA®) technology, has been a game-changer for their sample preparation workflow as a core facility by providing a flexible, efficient and […]

Careers & Hiring

3 pages
  1. Business Development Manager/career/business-development-manager
  2. Full Time Archives/job-type/full-time
  3. Manager, Reagents Manufacturing/career/manager-reagents-manufacturing

Pricing

6 pages
  1. E220evolution Instrument Service Plan/e220-evolution-service-plan

    Our service plan preventative maintenance includes a full system inspection, diagnostics, cleaning, calibration, and installation of software upgrades.

  2. Instant Finance Payment Calculator/financing-calculator

    [vc_row gap=”20″ el_class=”cmspage_menu” css=”.vc_custom_1583326403975{padding-top: 0px !important;}”][vc_column width=”1/4″ css=”.vc_custom_1586875605685{padding-top: 25px !important;padding-right: 0px !important;padding-left: 25px !important;background-color: #2d3e51 !important;}” el_class=”common_md-3″][vc_custom_heading text=”Instruments” font_container=”tag:h4|text_align:left|color:%23ffffff” use_theme_fonts=”yes” css=”.vc_custom_1580889773247{margin-bottom: 15px !important;}” el_class=”cus

  3. M220 Instrument Extended Warranty Plan/products-services-service-plans-m220-premium-onsite-plan

    Extended warranty service plan for the M220 Focused-ultrasonicator includes software upgrades, emergency service, technical support & parts replacement.

  4. ME220 Instrument Service Plan/me220-service-plan

About

3 pages
  1. About Us/about-covaris

    Our advanced sample preparation tools empower researchers to make novel discoveries, develop new assays and improve bioanalytical results.

  2. Commitment to Quality/commitment-to-quality

    Covaris is committed to providing high quality products and services that deliver trusted answers through an unwavering focus on fulfilling customer expectations, ensuring regulatory compliance, and fostering a culture of continuous improvement.

  3. Company/company

Homepage

1 page
  1. Homepage/

    Discover more with Covaris AFA-technology for rapid, reproducible, and high-recovery pre-analytical sample preparation across a variety of sample types.